Schedule 13G ownership disclosure
ZYNERBA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 98986X109
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,035,402
- Percent of class
- 3.5200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-019484
- Form type
- SC 13G
- Filer
- VANGUARD GROUP INC
- CIK
- CIK 102909
- Filed
- Feb 10, 2021
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership